Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma

ROBERT ILIEV, MICHAL FEDORKO, TANA MACHACKOVA, HANA MLCOCHOVA, MAREK SVOBODA, DALIBOR PACIK, JAN DOLEZEL, MICHAL STANIK and ONDREJ SLABY
Anticancer Research December 2016, 36 (12) 6419-6423;
ROBERT ILIEV
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
2Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAL FEDORKO
3Department of Urology, University Hospital Brno, Masaryk University, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: on.slaby{at}gmail.com fedorko.michal{at}fnbrno.cz
TANA MACHACKOVA
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANA MLCOCHOVA
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAREK SVOBODA
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
2Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DALIBOR PACIK
3Department of Urology, University Hospital Brno, Masaryk University, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN DOLEZEL
4Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAL STANIK
4Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ONDREJ SLABY
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
2Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: on.slaby{at}gmail.com fedorko.michal{at}fnbrno.cz
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 36 no. 12 6419-6423
PMID 
27919963

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 7, 2016
  • Revision received September 28, 2016
  • Accepted September 29, 2016
  • Published online December 5, 2016.

Copyright & Usage 
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ROBERT ILIEV1,2,
  2. MICHAL FEDORKO3⇑,
  3. TANA MACHACKOVA1,
  4. HANA MLCOCHOVA1,
  5. MAREK SVOBODA1,2,
  6. DALIBOR PACIK3,
  7. JAN DOLEZEL4,
  8. MICHAL STANIK4 and
  9. ONDREJ SLABY1,2⇑
  1. 1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
  2. 2Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  3. 3Department of Urology, University Hospital Brno, Masaryk University, Brno, Czech Republic
  4. 4Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  1. Correspondence to: Associate Professor Ondrej Slaby, Ph.D., Central European Institute of Technology (CEITEC), Masaryk University, University Campus Bohunice, Building A35, Room 217, Kamenice 5, 625 00 Brno, Czech Republic. Tel: +420 776494155, email: on.slaby{at}gmail.com and Michal Fedorko, MD, Department of Urology, University Hospital Brno, Jihlavska 340/20, 625 00 Brno, Czech Republic. Tel: +420 532231111, e-mail: fedorko.michal{at}fnbrno.cz
View Full Text

Statistics from Altmetric.com

Cited By...

  • 85 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 12
December 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma
ROBERT ILIEV, MICHAL FEDORKO, TANA MACHACKOVA, HANA MLCOCHOVA, MAREK SVOBODA, DALIBOR PACIK, JAN DOLEZEL, MICHAL STANIK, ONDREJ SLABY
Anticancer Research Dec 2016, 36 (12) 6419-6423;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma
ROBERT ILIEV, MICHAL FEDORKO, TANA MACHACKOVA, HANA MLCOCHOVA, MAREK SVOBODA, DALIBOR PACIK, JAN DOLEZEL, MICHAL STANIK, ONDREJ SLABY
Anticancer Research Dec 2016, 36 (12) 6419-6423;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma
  • Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer
  • Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma
  • Google Scholar

More in this TOC Section

  • Ginsenoside Rh4 Induces Apoptosis Through ROS-Mediated Fas Signaling in Human Nasopharyngeal Carcinoma NPC/HK1 Cells
  • Genome-wide Analysis Highlights rs4671908 and rs2238431 as Predictors of Survival in Nasopharyngeal Carcinoma
  • Implications of the Cuproptosis Protein SLC31A1 for the Immune Microenvironment and Temozolomide Sensitivity in Glioblastoma
Show more Experimental Studies

Keywords

  • PIWI-interacting RNA
  • piR-823
  • renal cell carcinoma
  • tumor tissue
  • blood serum
  • urine
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire